Cancer biopsy is a medical procedure that involves removal of cells or tissues from a person's body to examine them for signs of cancer under a microscope. It is used to help diagnose cancer, determine cancer prognosis, and guide cancer treatment. The global cancer biopsy market is driven by factors such as the rising prevalence of cancer across the globe, growing demand for minimally invasive biopsy procedures, technological advancements, and growing investment and funding activities.
Market key trends: The adoption of minimally invasive biopsy procedures has accelerated growth in the cancer biopsy market. Minimally invasive procedures involve small incisions and cause less damage to tissues as compared to traditional open biopsies. Medical devices manufacturers are developing advanced biopsy devices and techniques such as cryobiopsy and fine-needle aspiration biopsy that reduce complications, enhance targeting capabilities, and improve patient comfort. Furthermore, minimally invasive procedures allow sampling of tumor tissues in different areas with minimal trauma, which leads to better disease characterization. With increasing awareness about benefits of minimally invasive techniques, their adoption is expected to rise significantly during the forecast period.
Segment Analysis
The global cancer biopsy market is dominated by the needle biopsy segment. It is the most commonly performed biopsy method accounting for over 70% of the total procedures. Needle biopsies are minimally invasive, have faster recovery time, and cause less damage to tumors compared to surgical biopsies. This makes needle biopsy the preferred choice for initial tissue sampling to diagnose cancer or to reexamine tumors during follow-ups.
Key Takeaways
Global Cancer Biopsy Market Size is expected to witness high growth over the forecast period of 2024 to 2031. Advancing tissue sampling technologies along with rising cancer incidence worldwide are fueling the market expansion.
Regional analysis - North America is currently the dominant as well as the fastest growing regional market. Higher adoption of advanced biopsy devices and increasing biopsy procedures driven by the region's aging population and unhealthy lifestyle habits are promoting the regional market growth. Asia Pacific is witnessing rapid cancer biopsy market development riding on growing awareness, healthcare infrastructure enhancement and rising discretionary incomes in developing countries like India and China.
Key players - Key players operating in the cancer biopsy market are Atlassian Corporation Plc, Microsoft Corporation, Monday.com Ltd., Wrike, Inc., Asana, Inc., Jira Software, Smartsheet Inc., Trello, Inc., Basecamp LLC, Teamwork.com Ltd., Zoho Corporation Pvt. Ltd., Pivotal Software, Inc., VersionOne Inc., Clarizen Ltd., Targetprocess Inc. They are engaged in new product launches, partnerships and acquisitions to strengthen their market position.
Get More Insights On This Topic: https://www.trendingwebwire.com/cancer-biopsy-market-technology-propels-the-practice-of-precise-diagnosis/
Comments
0 comment